Abstract
Sam68 is a ubiquitously expressed KH-domain containing RNA-binding protein highly studied for its involvement in regulating multiple steps of RNA metabolism. Sam68 also contains multiple protein–protein interaction regions such as proline-rich regions, tyrosine phosphorylation sites, and arginine methylation sites, all of which facilitate its participation as an adaptor protein in multiple signaling pathways, likely independent of its RNA-binding role. This review focuses on providing a comprehensive report on the adaptor roles of Sam68 in inflammatory signaling and inflammatory diseases. The insights presented here have the potential to open new avenues in inflammation research and justify targeting Sam68 to control aberrant inflammatory responses.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Src-Associated in Mitosis 68 kDa Protein (Sam68), also known as KH Domain-Containing, RNA-Binding, Signal Transduction-Associated Protein 1 (KHDRBS1), belongs to the signal transduction and activation of RNA (STAR) family of proteins [1]. Sam68 plays key roles in cell proliferation, differentiation, development, signal transduction, and various aspects of RNA metabolism such as transcription, alternative splicing, and nuclear export [2, 3]. Sam68 contains a heteronuclear ribonucleoprotein particle K (hnRNP K) homology (KH) domain like other RNA-binding proteins in the STAR family. The KH domain is critical for the recognition and subsequent binding of Sam68 to the 3′ U(C/A)A(C/U) moiety commonly found on RNA. The KH domain is flanked by the highly conserved QUA1 region within the N-terminus (NK) and QUA2 region within the C-terminus (CK) of KH domain [3] (Fig. 1). The QUA1 region plays an important role in Sam68 dimerization, while the QUA2 region is responsible for recognizing a specific RNA sequence and stabilizing the dimer orientation via contact with the QUA1 and KH regions [3]. Together, the NK/QUA1, KH, and CK/QUA2 regions make up the STAR domain or GRP33/SAM68/GLD-1 (GSG) domain that is essential for RNA binding and homodimerization [1]. In addition to the STAR/GSG domain, Sam68 contains various regions that mediate protein–protein interactions as well as multiple posttranslational modification sites (Table 1). The C-terminus of Sam68 contains tyrosine residues which are phosphorylated, which mediate binding to SH2 domain-containing proteins (Table 1) [2]. The protein’s six proline-rich regions allow for binding to SH3 domains of Src kinases, which regulate a wide variety of cellular functions such as cell proliferation, survival, and migration [4,5,6]. The tyrosine phosphorylation-dependent SH2 domain protein binding and proline-rich region-dependent SH3 domain binding have been shown to inhibit Sam68’s interaction with RNA and facilitate its function as an adaptor molecule in signaling involved in cell cycle progression and cell proliferation (Table 1) [2]. In addition to phosphorylation, other posttranslational modifications, including O-GlcNAcylation [7], arginine methylation [8], SUMOylation [9], and acetylation [10], control cellular functions of Sam68 (Table 1). Lin et al., reported that the O-GlcNAcylation of Sam68 plays a role in modulating lung cancer cell migration and invasion [7]. Arginine methylation of Sam68 by the protein arginine methyltransferase 1 (PRMT1) has been shown to decrease the RNA-binding ability of Sam68, modulating its protein interactions and controlling its localization and function [8, 11]. Sam68 is SUMOylated by SUMO ligase PIAS1, which results in the repression of cyclin D1 leading to G1 arrest and inhibition of cell proliferation (Table 1). However, it is unclear whether SUMOylation of Sam68 has any effect on the RNA-binding affinity of Sam68 and protein–protein interactions [9]. The RNA-binding domain is required for Sam68 apoptosis induction, while acetylation of Sam68 enhances its RNA-binding ability and may upregulate pro-apoptotic proteins [9]. Sam68 also contains a nuclear localization signal (NLS) in its C-terminus which allows the protein to move between the cytoplasm and nucleus of the cell, as well as execute its many transcriptional and posttranscriptional regulatory roles [2].
The lion’s share of the studies on Sam68 focuses on its roles in RNA binding and cancer [1, 12, 13]. Sam68 has also been shown to play a critical role as an adaptor protein in various signaling pathways such as insulin [14, 15], leptin [14, 15], T-cell receptor (TCR) and B-cell receptor (BCR) [14, 16], tumor necrosis factor (TNF) [6], and toll-like receptor (TLR) [17]. Recent findings suggest that higher expression levels of Sam68 are not only associated with various human cancers [1, 2, 18], but also with inflammatory diseases such as inflammatory bowel disease [19], arthritis [20], and arterial injury [21]. For example, the high levels of Sam68 observed in patients with ulcerative colitis (UC) correlated with higher levels of apoptosis and NF-κB activation [19]. As such, Sam68’s role in driving inflammation through NF-κB signaling and inhibition of wound repair processes has been linked to worsened patient outcomes across various inflammatory diseases [19, 21]. Understanding Sam68-dependent inflammatory signaling pathways and delineating the multifaceted effects of Sam68 on inflammation may improve patient prognosis and drive therapeutic development for inflammatory diseases. In this review, we highlight Sam68’s adaptor role in inflammatory diseases and discuss its potential as a therapeutic target.
Sam68 as an adaptor protein
Adaptor proteins are essential for the propagation, amplification, and regulation of cellular signals [22]. In inflammatory signaling, adaptor proteins may play an essential role in both the specificity and diversity of cellular responses to inflammation, as well as to resolve inflammatory signaling before it becomes pathologic [23]. Sam68, first identified as an RNA-binding protein, has been shown to serve as an adaptor protein in an array of inflammatory signaling events, notably at the upstream-receptor level.
Role of Sam68 in TCR signaling
The TCR enables T cells to recognize foreign antigens and signal to mount immune and inflammatory responses. TCR activation initiates a signaling cascade which triggers the recruitment of several cytoplasmic proteins to the receptor [24, 25]. The presence of proline-rich regions allows for Sam68’s interactions with SH3 domain containing adaptors such as Grb2 (Fig. 2A) [26] and the Src family tyrosine kinases, Fyn and Lck [27, 28]. These interactions may occur at the basal state, as they do not involve any stimulus-dependent posttranslational modifications. The six proline-rich domains throughout Sam68 are notably not clustered to one particular terminus, resulting in a spatially heterogeneous distribution of SH3 domain-binding motifs on Sam68 [29]. It is also possible that the conformational changes in the three-dimensional structure of Sam68, upon carboxy-terminal SH2 binding, may allow for a differential display of one or more proline-rich regions. Importantly, this would promote more efficient binding to SH3 domain containing proteins or binding to more than one SH3 domain containing protein, facilitating an essential adaptor/scaffolding role in propagating downstream TCR signaling. Furthermore, the binding of one SH3 domain-containing protein may also expose additional proline-rich regions or result in tyrosine phosphorylation of Sam68, thus allowing additional recruitment of both SH3 and SH2 domain containing proteins.
In contrast, Sam68’s binding to SH2 domain containing proteins is dependent on its tyrosine phosphorylation, which may happen only after TCR activation. TCR engagement results in the recruitment of several proteins along with multiple kinases such as Lck and Fyn, both of which contain SH3 and SH2 domains to facilitate the binding of non-phosphorylated and phosphorylated forms of Sam68. It is possible that the initial binding of Sam68 to the TCR complex is mediated through its interaction with the SH3 domain-containing proteins followed by its tyrosine phosphorylation. It is observed in in vitro studies that once tyrosine phosphorylation has occurred, Sam68 may also bind to the adaptor proteins such as ZAP-70 and SLP-76 and phosphoinositide 3-kinase (PI3K) as well as activate mitogen-activated protein kinase (MAPK) pathways (Fig. 2A) [25, 30]. Thus, through the interactions via proline-rich regions and tyrosine phosphorylated regions, Sam68 may perform its adaptor function in linking multiple proteins’ binding to the ζ chain of the TCR’s CD3, as well as to the intracellular domains of CD4/CD8, CD28, and linker for activation of T cells (LAT) (Fig. 2A).
Absence of Sam68 has been shown to significantly reduce the TCR-induced inflammatory interferon (IFN)-γ production in T helper 1 (Th1) cells. This was primarily attributed to Sam68’s ability to bind and inhibit microRNA-29, which inhibits the transcription factors T-bet and Eomes which control IFN-γ expression in T cells [31]. It remains to be investigated whether the adaptor function of Sam68 at the TCR also contributes to IFN-γ expression in T cells. Furthermore, Sam68 has been shown to be an essential non-Rel component of the NF-κB complex inducing CD25 expression in T cells [16] (Fig. 2A). T-cell activation results in IKKα-dependent serine phosphorylation of nuclear Sam68 and its binding to the NF-κB p65 subunit, and subsequent binding of this Sam68-p65 complex to the CD25 promoter. This alludes to an important nuclear-adaptor role of Sam68 in regulating gene expression. Because Sam68-p65 binding does not directly involve SH2/SH3 domain-dependent interactions, knowledge of the precise mechanism of Sam68-p65 binding in T cells is expected to reveal novel binding mechanisms through which Sam68 executes its adaptor role in the nucleus. Notably, some contradictions exist within the cytoplasmic adaptor role of Sam68 in TCR signaling. In a well-performed study, Fu et al. [16] showed that siRNA suppression of Sam68 in Jurkat cells did not prevent TCR activation and that PMA/ionomycin stimulation induced IκBα degradation. This raised the possibility that Sam68 may not be essential in cytoplasmic signaling events in T cells leading to NF-κB activation. However, the siRNA-mediated suppression of Sam68 in this study leaves a significant amount of residual Sam68 in the cells, which may suffice for signal transduction. Hence, to derive firm conclusions on the adaptor role of Sam68 in TCR signaling, it is necessary to conduct comprehensive studies using complete Sam68 knockout T cells and delineate downstream signaling following both CD3 activation alone and with CD3 and CD28 co-stimulation. Moreover, given the presence of multiple potential binding partners for Sam68 in the TCR complex and in the nucleus, a clearer understanding of the direct and indirect binding partners of Sam68 is necessary to elucidate the biochemical mechanisms by which Sam68 adapts TCR signaling.
Role of Sam68 in BCR signaling
B cells are another major component of the adaptive immune system with a major role in antibody production [32]. They also partake in antigen presentation and secrete multiple cytokines that control immune response [33]. The BCR recognizes and binds to foreign antigens, leading to B cell activation and propagation of signaling via phosphorylation of multiple kinases including Lyn, Btk and PI3K at the BCR complex [34]. Sam68 interacts with the PI3K–SH2 domain through its phosphotyrosine region [34, 35] and the Btk–SH3 domain through its proline-rich regions (Fig. 2B) [36]. The proline-rich regions were also shown to control B cell signal transduction regulating cell growth and death [4]. Lyn kinase has been shown to phosphorylate Sam68 [37], but its direct interaction with Sam68 in B cells remains to be demonstrated. Lyn kinase has also been shown to be required for the activation of Syk kinase, which involves trans- and auto-phosphorylation events [38]. It is highly likely that the activated Syk kinase may interact with and phosphorylate Sam68 propagating downstream BCR signaling involving Lyn and Btk kinases [36, 38,39,40] based on the potential of Syk to phosphorylate Sam68 in vitro [41]. Sam68 has also been shown to interact with several other SH2 and SH3 domain-containing proteins that are associated in the BCR complex such as Grb2, PLC-gamma, and RAS GTPase activating protein (Ras-GAP) [42, 43]. Through this multiprotein binding ability, Sam68 is likely to control downstream signaling pathways activated following BCR stimulation such as NF-κB, nuclear factor of activated T-cells (NFAT), p38, JNK, ERK, and AKT. The role of Sam68 in adapting these kinases/pathways in BCR signaling remains a vast area inviting comprehensive investigation.
Role of Sam68 in insulin receptor (IR) signaling
Insulin binding to the IR results in tyrosine phosphorylation of insulin receptor substrate 1 (IRS1) and downstream signaling cascade activation [44]. Sam68 has been shown to bind to IRS1 at the basal state and this interaction enhances following insulin stimulation, with an associated increase in Sam68 protein level both in the cytoplasm and at the IR. At the IR, Sam68 associates with PI3K via the SH2 domain of the p85 subunit (Fig. 3), a main downstream constituent of insulin signaling [46]. Insulin signaling also causes tyrosine phosphorylation of Sam68 enabling its interaction with SH2 domain containing proteins such as GAP and PI3K, both in vitro and in vivo [26, 35, 45]. Sam68 also has the ability to bind and recruit p120GAP to the PI3K pathway [26], possibly through interaction with the SH2 domain. The simultaneous association of Sam68 with p85 PI3K and GAP help to bring these two molecules together, thus linking PI3K with the RAS pathway in IR signaling (Fig. 3) [35, 47]. On the other hand, Sam68 is known to be associated with the SH3 domains of Grb2 independent of insulin stimulation in vivo; however, insulin stimulation has been shown to promote Sam68 phosphorylation and its association with the SH2 domains of GAP. This in turn promotes association of GAP with the Grb2–SOS complex. Both of these complexes lead to the downstream activation of the MAP kinase pathway, influencing metabolic and mitogenic gene expression (Fig. 3) [26]. Overall, current evidences show that Sam68 is a substrate phosphorylated in insulin signaling, and that it also acts as an adaptor linking multiple proteins at the IR. Most of the current knowledge on the role of Sam68 in IR signaling are derived from in vitro studies using cell lines and their physiological significance remains to be validated through in vivo studies. Possible IR-independent adaptor roles of Sam68 in the cytoplasm that may control inflammatory signaling and insulin resistance, as well the potential nuclear roles of Sam68 regulating insulin-dependent gene expression, are interesting areas pending investigation. The relationship between inflammation and insulin resistance has been well studied [48,49,50], but there remain further avenues of investigation. For example, pro-inflammatory cytokines are also known to induce the activation of serine and threonine kinases, which can in turn cause inhibitory phosphorylation of IRS1 and impede downstream signaling by IRS1 [44]. Whether inflammation in the context of IR signaling also causes serine/threonine phosphorylation of Sam68 has yet to be determined.
Role of Sam68 in leptin receptor signaling
Sam68 regulates leptin receptor signaling both through its RNA-binding function and as an adaptor protein. First, through its RNA-binding role, Sam68 has been shown to skew leptin receptor mRNA expression to its long isoform under physiological conditions [51]. The long isoform of the leptin receptor, or OB-Rb, facilitates pro-inflammatory responses in macrophages by inducing the secretion of the cytokines IL-6 and TNF [52, 53]. Importantly, the activation of pro-inflammatory receptors such as TLR4 (LPS activation), tumor necrosis factor receptor-1 (TNFR1) (TNF activation), and IL-1R (IL-1β activation) increases the circulating levels of leptin, which in turn is able to drive increased serum levels of the pro-inflammatory cytokines, e.g., TNF, IL-6, and IL-12 [53]. What then forms is a positive-feedback loop of inflammatory cytokine release, initially spawned by adipokines dependent upon Sam68 as an adaptor within the leptin receptor’s downstream signaling cascade. Activation of the leptin receptor triggers multiple pathways such as JAK–STAT, MAPK, and PI3K [54]. Signaling through OB-Rb induces Sam68 tyrosine phosphorylation resulting in decreased poly(U)-binding capacity, limiting mRNA processing function of Sam68 [51], and increasing its association with PI3K’s SH2 domain (Fig. 4). Similarly, leptin also stimulates tyrosine phosphorylation of Sam68 in a time and dose dependent manner, promoting its association with STAT3 via SH2 domain interaction in vitro (Fig. 4) [14]. To understand the molecular mechanisms of leptin receptor signal transduction pathway involving Sam68, it is necessary to first identify the SH2 domain containing proteins that are activated by the leptin receptor. SH2 domain containing protein tyrosine phosphatase 2 (SHP-2) is one such protein that has been shown to bind to phospho-tyrosine 985 of Ob-Rb upon leptin treatment; the bound SHP-2 itself was tyrosine phosphorylated following leptin stimulation (Fig. 4). While STAT3 downstream phosphorylation has been shown to be independent of SHP-2 phosphorylation, Li and Friedman have shown that the downstream-phosphorylation level of JAK2 is significantly decreased upon SHP-2 activation via leptin receptor signaling [55]. However, it is not yet known whether Sam68 has any role in SHP-2 regulated leptin receptor signal transduction through binding to the SH2 domain of SHP-2. It would prove interesting to see if Sam68 has a role in facilitating SHP-2 activation, which may then result in modulation of the leptin receptor signaling cascade. The current understanding on the role of Sam68 in leptin receptor signaling is mostly based on in vitro studies. Hence, further comprehensive in vivo studies are necessary to delineate the physiological role of Sam68 in leptin receptor signaling.
Role of Sam68 in TNFR1 signaling
TNFR1 is a ubiquitously expressed cell surface receptor associated with a variety of inflammatory and autoimmune pathologies [56]. TNF stimulation induces binding of Sam68 to the TNFR1 receptor [6], which then results in rapid activation of a complex containing TRADD, TNF receptor-associated factor 2 (TRAF2), cIAP1/2, and receptor-interacting protein kinase 1 (RIPK1) to instigate the activation of the signalosome complex containing IKKα, IKKβ and NEMO. Activated IKKβ then phosphorylates the inhibitory subunit of NF-κB, or IκB, leading to its proteolytic degradation and NF-κB activation (Fig. 5). With prolonged TNF stimulation, a second complex containing Sam68, RIPK1, FADD, and caspase 8 is formed to direct the signal toward an apoptotic cellular response [6]. Sam68, as an adaptor, is required upstream for the proper formation and activation of these NF-κB and apoptosis activating complexes. When Sam68 is removed or inhibited, TNFR1 demonstrates ablated inflammatory/death signaling responses (Fig. 5) [6, 20]. In vitro binding studies have shown that Sam68 directly binds to TNFR, TRAF2, and RIPK1, and preliminary deletion studies show that the absence of the KH domain region in Sam68 compromised the protein’s binding to the TNFR [6]. Because these bindings are likely not directly dependent upon the SH2/SH3-binding potential of Sam68, further biochemical characterization is necessary to decipher the exact binding domains of Sam68 that allows its adaptor role in the TNFR1 pathway. It is also possible that there is an accessory protein which links Sam68 to TNFR1. An example may be Grb2 with the SH2/SH3 domains, as it has previously been shown to partake in TNFR1 signaling [57]. Finally, the apoptotic function of Sam68 has been shown to be negatively regulated by SUMOylation at its N terminus [9]; however, how SUMOylation affects protein–protein interactions and adaptor function of Sam68 warrants detailed future studies.
Role of Sam68 in TLR signaling
The TLR family is a major component of the innate immune system implicated in a variety of autoimmune and inflammatory diseases with both pro- and anti-inflammatory roles [58,59,60,61]. Sam68 has been shown to be required for the activation of two TLR2 pathways (TLR2/1 and TLR2/6) and TLR3 activation, and is partially required for TLR4 signaling (Fig. 6) [17]. During pathologic inflammation driven by TLR activation, Sam68 appears to serve as a crux in both MyD88 and TRIF adapted cascades downstream of the TLRs. Furthermore, it has been found that when TLR2 and TLR3 are activated in Sam68-deficient cells, a differential nuclear translocation of NF-κB subunits is observed; while c-Rel translocation was found dependent on Sam68, p65 translocation showed only partial Sam68 dependence. Sam68 was shown to be essential for the expression of selected genes following TLR2 activation, yet not TLR3 activation, in macrophages. This suggests a plausible non-redundant transcriptional role for c-Rel containing NF-κB dimers activated by TLR2 in a Sam68-dependent manner. It appears that in case of TLR3 activation, the absence of Sam68 and resulting loss of nuclear c-Rel may be partially compensated by p65 containing dimers (Fig. 6) [17]. While it has been demonstrated that both MyD88- and TRIF-dependent signaling require Sam68 for optimal NF-κB activation, the exact binding partners of Sam68 or protein-complex(es) containing Sam68 at the receptor level or in the cytoplasm in TLR signaling remain unknown. It would be interesting to learn the biochemical and mechanistic differences in signaling involving Sam68 at the endosomal level by comparatively studying TLR2 vs TLR3 signaling that signals through MyD88 and TRIF, respectively. In addition, how Sam68 functions in the two complexes associated with TLR4, one at the membrane and another at the endosome, also warrants future investigation (Fig. 6). Furthermore, much like what is observed in Leptin signaling, TLR signaling is known to readily induce TNF production [62], which would further contribute to a positive-pro-inflammatory feedback loop maintained by Sam68 adapting multiple overlapping pathways.
Role of Sam68 in inflammatory diseases
Sam68 functions as a scaffold in signal transduction pathways and transcription complexes through protein–protein interactions, controlling a variety of biological activities. Sam68 is required for both TNF and TLR-mediated NF-κB signaling [6, 17], and a number of studies have found it to be a key inflammatory driver in a variety of pathophysiological processes, including chronic auto-inflammatory disorders such as UC [19], arthritis [20], and arterial injury [21] (Fig. 7). Overall, Sam68 overexpression correlates with chronic pro-inflammatory NF-κB signaling and increased apoptosis [5, 19,20,21].
Arthritis
Osteoarthritis (OA) is the most common musculoskeletal disorder and the leading cause of disability worldwide [63]. Although OA is characterized by progressive destruction of articular cartilage [64], it is also associated with a complex pathogenesis that affects all tissues within the joint [65]. It has been reported that chronic inflammation and apoptosis have close relationships with OA progression [66, 67]. Multiple evidence indicates the potential role of Sam68 in NF-κB activation and inflammation as well as in TNF-receptor mediated apoptosis [6, 17, 21]. Sam68 expression has been shown to be elevated in OA cartilage tissues and chondrocytes upon TNF stimulation, along with increased expression of apoptotic markers such as cleaved caspase-3 and cleaved PARP [20]. Sam68 deletion significantly reduced the expression of the apoptotic markers and NF-κB dependent catabolic markers such as interleukin-6 (IL-6), A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)-5, inducible nitric oxide synthase (iNOS) and matrix metalloproteinase (MMP)-13, as well as hindered IκB degradation and nuclear translocation of NF-κB p65. These findings also align with the suggested adaptor role of Sam68 in the TNFR signaling complex leading to NF-κB activation and apoptosis induction [6], executing a critical role in the pathophysiology of OA [20].
Rheumatoid arthritis (RA) is another chronic, destructive form of arthritis which is characterized by polyarthritis, joint destruction, and functional impairment [68]. Complex networks of pro-inflammatory cytokines, chemokines, and growth factors play a fundamental role in its pathogenesis. However, given the considerable variation in clinical courses and therapeutic responses of RA patients, the precise pathophysiological pathways involved in the etiology and progression of RA is only partially understood [69]. NF-κB signaling pathway mediated inflammation plays a key role in the pathogenesis of RA [70]. The relevance of Sam68 in this pathway appears to rest in its ability to bind to the p65 subunit of NF-κB in the nucleus, promoting transcription of several NF-Κb-dependent inflammatory genes [16, 71]. However, it remains unknown as to how Sam68 modulates NF-κB-DNA interactions. It is possible that Sam68 alters the NF-κB dimer composition, modifies the affinity of the NF-κB-DNA interaction, or directly interacts with the NF-κB-binding regions on the promoter region to alter transcription. Sam68 expression was shown to be markedly elevated in RA patients' synovial tissue, where it co-localizes with THY1, a marker for fibroblast-like synoviocytes (FLS), indicating that overexpression of Sam68 contributes to pathology of synovial inflammation in RA [5]. In addition, Sam68 expression was increased in FLS in response to TNF stimulation in a time-dependent manner. Suppression of Sam68 by siRNA dramatically reduced the expression of TNF-induced cytokines and FLS proliferation, migration, and invasion, along with reduced phosphorylation of p65 and IκBα. Collectively, these data highlight Sam68's role in RA inflammation through NF-κB signaling pathway [5] and leave opportunity for mechanistic and translational studies focusing on Sam68 open for future investigations.
Inflammatory bowel diseases (IBD)
IBD, which include UC and Crohn's disease (CD), are chronic mucosal inflammatory disorders of the intestine [72, 73]. The intestinal epithelial cells (IEC) regulate intestinal homeostasis by participating in coordinated responses to signals from the microbiota and local leukocyte populations [74, 75]. Compromised epithelial homeostasis associated with increased cytokine production, leukocyte infiltration, and IEC apoptosis are suggested factors of IBD pathogenesis; however, the molecular mechanisms involved remain poorly defined [76,77,78]. Therefore, identification of novel signaling mechanisms in IBD remains a challenge [19].
Previous works have identified critical roles of TNFR and TLR mediated pro-inflammatory signaling in IBD [58, 79]. Strategies targeting TNFR to control inflammation are among the frontline therapeutic strategies for IBD [80], but they often result in partial success and a high rate of relapse [81]. Targeting TLR pathway is another emerging potential therapeutic approach for treating IBD [58]. Sam68 has been reported as a critical mediator of both TNFR and TLR mediated signaling [6, 17]. Although Sam68 has shown to be necessary for TLR-induced inflammatory signaling, the precise, mechanistic role and the biochemistry of Sam68 in TLR signaling has not been studied in detail. In contrast, sufficient foundational knowledge exists on the mechanistic role of Sam68 in TNFR signaling [6]. Absence of Sam68 was shown to compromise TNF-induced inflammation in human colon cell lines and in DSS-induced experimental mouse IBD model [19, 82] and global deficiency of Sam68 was shown to protect mice from colon inflammation and development of experimental colitis [19]. Of note, both the levels of Sam68 and pro-inflammatory gene expression were reported to be significantly elevated in the colon biopsies of UC patients, suggesting a potential role of Sam68 in UC pathogenesis [82]. Whether elevation of Sam68 is a cause or consequence of UC is an interesting question that is worthy of investigation. In addition to its role in NF-κB activation and inflammatory signaling, Sam68 also binds to the TNF-induced apoptosome complex containing caspase 8, mediating programmed cell death [6]. IEC damage, recovery, and death are perpetuating events in UC and there has yet to be a comprehensive study on how Sam68 expression levels and functions regulate these processes. Studies on the possible roles of Sam68 in the mechanisms involved in UC showed that it is required for NF-κB activation promoting catabolic gene expression and caspase-mediated IEC apoptosis [82]. Sam68 deficiency in HT29 cells significantly reduced TNFα-induced Iκ-Bα degradation and attenuated p65 nuclear translocation, corroborating earlier studies and further demonstrating Sam68's critical function in IEC apoptosis and the UC pathogenesis through NF-κB-mediated inflammation [82]. Initial study of cell type specific function of Sam68 suggests that hematopoietic cell-specific Sam68 may not play a substantial role in the pathogenesis of acute experimental colitis in mice, alluding to Sam68’s function in the non-hematopoietic compartment as a regulator of intestinal inflammation [19]. Further studies using IEC-specific Sam68 knockout mouse models are necessary to delineate the epithelial role of Sam68 in IBD. Overall, given its function in TNF- and TLR-mediated inflammation, Sam68 may prove a potential therapeutic target for the treatment of UC and potentially IBD with fewer side effects than the global TNF inhibition currently recommended in the clinic for IBD.
Cardiovascular diseases
The function of Sam68 in cardiovascular biology is not yet well understood. Sam68 has been shown to be involved in vascular inflammatory response to denudation injury, likely through its role in TNF/NF-κB signaling. Sam68 interacts with Filamin A (FLNA) to stabilize TRAF2 on the cytoskeleton, which in turn amplifies NF-κB signaling and encourages the inflammatory response in arterial damage [21]. Sam68 deletion was shown to reduce neointima hyperplasia, associated with a reduction in macrophage infiltration and downregulation of pro-inflammatory genes in damaged arteries. Moreover, bone marrow transplantation from Sam68-deficient mice to WT mice increased vascular remodeling, suggesting a potential proinflammatory role of Sam68 in hematopoietic cells in regulating vasculature [21]. The question as to whether the positive regulation of vascular remodeling by Sam68 deficient bone marrow cells demonstrates an inhibitory role of Sam68 in this process remains unanswered. Apart from cytokine and immune cell-mediated inflammation, Sam68 has also been shown to regulate angiotensin II (ANG II) receptor signaling in vascular smooth muscle cells (VSMC). ANG II stimulation increases Sam68 phosphorylation and its binding to PI3K and these processes are associated with altered VSMC growth and vascular changes in hypertension, which is one of the prominent risk factors in cardiovascular diseases [83]. The upstream kinases that phosphorylate Sam68, precise role of cytoplasmic or nuclear Sam68 as well as RNA-binding dependent and independent roles of Sam68 in regulating VSMC growth in hypertension, are all topics that remain to be explored.
Sam68 as a potential therapeutic target
Sam68's emergence as a key STAR protein is the result of its apparent multifunctionality as an RNA-binding protein and signaling adaptor, mediating protein–protein interactions in multiple pathways in various cell types [84]. Several reports also indicate that Sam68 undergoes various posttranslational modifications which can alter its function in propagating signal transduction [6]. Sam68 is downstream of the TNFRs [6], hepatocyte growth factor (HGF)/Met receptor [85], leptin, insulin, and epidermal growth factor (EGF) receptors [86, 87]. Moreover, emerging evidence reveals the potential of Sam68 to control the pathological processes of ataxia, osteoporosis, cancer, obesity, and IBD [87].
Sam68 has also been documented as a Cyclic Adenosine Monophosphate-Response-Element-Binding protein (CREB)-Binding Protein (CBP) binding partner which can repress abrupted Wnt/β-catenin signaling. As a result, Sam68 has been identified as a selective target and mediator of Wnt/β-catenin regulation in human cancer stem cells [88]. Abnormalities in the WNT/β-catenin pathway have been implicated in the manifestation of many types of human diseases including cancer [88, 89]. Treatment of cells with the ICG and CWP families of small molecules (such as ICG-001 and CWP232291) mechanistically disrupts the interaction between CBP and β-catenin via the promotion of a Sam68/CBP complex, which in turn alters CBP/β-catenin-dependent transcription to promote apoptosis and differentiation [88]. Similarly, CWP232228, an analog of the inhibitor ICG-001, a compound related to CWP232291, has also been reported to induce the Sam68–CBP complex formation, impairing transcription of known Wnt pathway target genes [88]. A recent finding identified Sam68 as a primary target of reverse-turn peptidomimetic small molecules (i.e., YB-0158) like CWP232228. YB-0158 treatment leads to the disruption of Sam68–Src protein interactions which results in significant accumulation of Sam68 in the nucleus. This nuclear shuttling of Sam68 enhances the formation of Sam68–CBP complexes, thereby avoiding the CBP/β-catenin interaction altogether [90]. Sam68 has also been suggested to be a potential target of sunitinib malate, a widely used first‐line drug for metastatic renal cell carcinoma (RCC) [91]. Wu et al., have demonstrated that sunitinib treatment significantly inhibits the total expression and phosphorylation of Sam68 in RCC cell lines. As further evidence, sunitinib sensitivity in ccRCC (clear cell renal cell carcinoma) patients was found to be dependent on increased Sam68 expression levels in sunitinib-sensitive RCC tumor tissues when compared to sunitinib-resistant tissues [91].
Conclusions and future directions
Current knowledge of Sam68’s role in regulating protein–protein interactions and signal transduction is limited, with most of its functions attributed to RNA binding. With no enzymatic activity and an abundance of spatially distributed functional domains such as proline-rich regions, multiple tyrosine phosphorylation sites and nuclear localization signal, Sam68 earns the apt title of an ubiquitous adaptor protein. The multiple arginine methylation sites of Sam68 may also regulate protein–protein interactions which will serve to further broaden the spectrum of potential binding partners of Sam68 [92]. One key area which warrants future investigation is the identification of discrete functional domains and/or posttranslational modifications of Sam68 that dictate its RNA-binding and protein-binding roles in a cell type and disease-specific manner. It is also important to investigate the unique and overlapping roles of Sam68 in immune and inflammatory signaling pathways, a necessity when designing specific therapeutic agents targeting distinct functions of Sam68 such as inflammation, cell proliferation, and cell death. Because Sam68 is an intracellular protein, strategies to develop therapeutic compounds targeting Sam68 that are cell permeable with adequate stability and bioavailability are essential. Thus, there exists ample need and large scope for further comprehensive studies on Sam68 which may lead to substantial new therapeutic opportunities targeting this STAR protein in chronic inflammatory diseases.
Availability of data and materials
This review does not contain any new original data. All data discussed here are cited in the references.
References
Bielli P, Busà R, Paronetto MP, Sette C (2011) The RNA-binding protein Sam68 is a multifunctional player in human cancer. Endocr Relat Cancer 18(4):R91–R102. https://doi.org/10.1530/erc-11-0041
Frisone P, Pradella D, Di Matteo A, Belloni E, Ghigna C, Paronetto MP (2015) SAM68: signal transduction and RNA metabolism in human cancer. Biomed Res Int 2015:528954. https://doi.org/10.1155/2015/528954
Feracci M, Foot JN, Grellscheid SN et al (2016) Structural basis of RNA recognition and dimerization by the STAR proteins T-STAR and Sam68. Nat Commun 7(1):10355. https://doi.org/10.1038/ncomms10355
Li QH, Fan TX, Pang TX, Yuan WS, Han ZC (2006) Effect of proline rich domain of an RNA-binding protein Sam68 in cell growth process, death and B cell signal transduction. Chin Med J 119(18):1536–1542
Sun W, Qin R, Wang R et al (2018) Sam68 promotes invasion, migration, and proliferation of fibroblast-like synoviocytes by enhancing the NF-κB/P65 pathway in rheumatoid arthritis. Inflammation 41(5):1661–1670. https://doi.org/10.1007/s10753-018-0809-4
Ramakrishnan P, Baltimore D (2011) Sam68 is required for both NF-κB activation and apoptosis signaling by the TNF receptor. Mol Cell 43(2):167–179. https://doi.org/10.1016/j.molcel.2011.05.007
Lin C-H, Liao C-C, Wang S-Y et al (2022) Comparative O-GlcNAc proteomic analysis reveals a role of O-GlcNAcylated SAM68 in lung cancer aggressiveness. Cancers 14(1):243
Côté J, Boisvert FM, Boulanger MC, Bedford MT, Richard S (2003) Sam68 RNA binding protein is an in vivo substrate for protein arginine N-methyltransferase 1. Mol Biol Cell 14(1):274–287. https://doi.org/10.1091/mbc.e02-08-0484
Babic I, Cherry E, Fujita DJ (2006) SUMO modification of Sam68 enhances its ability to repress cyclin D1 expression and inhibits its ability to induce apoptosis. Oncogene 25(36):4955–4964. https://doi.org/10.1038/sj.onc.1209504
Babic I, Jakymiw A, Fujita DJ (2004) The RNA binding protein Sam68 is acetylated in tumor cell lines, and its acetylation correlates with enhanced RNA binding activity. Oncogene 23(21):3781–3789. https://doi.org/10.1038/sj.onc.1207484
Rho J, Choi S, Jung CR, Im DS (2007) Arginine methylation of Sam68 and SLM proteins negatively regulates their poly(U) RNA binding activity. Arch Biochem Biophys 466(1):49–57. https://doi.org/10.1016/j.abb.2007.07.017
Zhao J, Li J, Hassan W, Xu D, Wang X, Huang Z (2020) Sam68 promotes aerobic glycolysis in colorectal cancer by regulating PKM2 alternative splicing. Ann Transl Med 8(7):459
Stockley J, Markert E, Zhou Y et al (2015) The RNA-binding protein Sam68 regulates expression and transcription function of the androgen receptor splice variant AR-V7. Sci Rep 5(1):1–13
Najib S, Martín-Romero C, González-Yanes C, Sánchez-Margalet V (2005) Role of Sam68 as an adaptor protein in signal transduction. Cell Mol Life Sci CMLS 62(1):36–43. https://doi.org/10.1007/s00018-004-4309-3
Pérez-Pérez A, Sánchez-Jiménez F, Vilariño-García T, de la Cruz L, Virizuela JA, Sánchez-Margalet V (2016) Sam68 mediates the activation of insulin and leptin signalling in breast cancer cells. PLoS ONE 11(7):e0158218. https://doi.org/10.1371/journal.pone.0158218
Fu K, Sun X, Zheng W et al (2013) Sam68 modulates the promoter specificity of NF-κB and mediates expression of CD25 in activated T cells. Nat Commun 4:1909. https://doi.org/10.1038/ncomms2916
Tomalka JA, de Jesus TJ, Ramakrishnan P (2017) Sam68 is a regulator of Toll-like receptor signaling. Cell Mol Immunol 14(1):107–117. https://doi.org/10.1038/cmi.2016.32
Xiao J, Wang Q, Yang Q et al (2018) Clinical significance and effect of Sam68 expression in gastric cancer. Oncol Lett 15(4):4745–4752. https://doi.org/10.3892/ol.2018.7930
Goodman WA, Basavarajappa SC, Liu AR, Rodriguez FDS, Mathes T, Ramakrishnan P (2021) Sam68 contributes to intestinal inflammation in experimental and human colitis. Cell Mol Life Sci CMLS 78(23):7635–7648. https://doi.org/10.1007/s00018-021-03976-7
Xu L, Sun C, Zhang S et al (2015) Sam68 promotes NF-κB activation and apoptosis signaling in articular chondrocytes during osteoarthritis. Inflamm Res 64(11):895–902. https://doi.org/10.1007/s00011-015-0872-3
Han S, Xu S, Zhou J et al (2019) Sam68 impedes the recovery of arterial injury by augmenting inflammatory response. J Mol Cell Cardiol 137:82–92. https://doi.org/10.1016/j.yjmcc.2019.10.003
Jordan MS, Singer AL, Koretzky GA (2003) Adaptors as central mediators of signal transduction in immune cells. Nat Immunol 4(2):110–116. https://doi.org/10.1038/ni0203-110
Borowicz P, Chan H, Hauge A, Spurkland A (2020) Adaptor proteins: Flexible and dynamic modulators of immune cell signalling. Scand J Immunol 92(5):e12951. https://doi.org/10.1111/sji.12951
Hwang JR, Byeon Y, Kim D, Park SG (2020) Recent insights of T cell receptor-mediated signaling pathways for T cell activation and development. Exp Mol Med 52(5):750–761. https://doi.org/10.1038/s12276-020-0435-8
Lang V, Mège D, Semichon M, Gary-Gouy H, Bismuth G (1997) A dual participation of ZAP-70 and scr protein tyrosine kinases is required for TCR-induced tyrosine phosphorylation of Sam68 in Jurkat T cells. Eur J Immunol 27(12):3360–3367. https://doi.org/10.1002/eji.1830271235
Najib S, Sánchez-Margalet V (2002) Sam68 associates with the SH3 domains of Grb2 recruiting GAP to the Grb2-SOS complex in insulin receptor signaling. J Cell Biochem 86(1):99–106. https://doi.org/10.1002/jcb.10198
Fusaki N, Iwamatsu A, Iwashima M, Fujisawa J (1997) Interaction between Sam68 and Src family tyrosine kinases, Fyn and Lck, in T cell receptor signaling. J Biol Chem 272(10):6214–6219. https://doi.org/10.1074/jbc.272.10.6214
Salmond RJ, Filby A, Qureshi I, Caserta S, Zamoyska R (2009) T-cell receptor proximal signaling via the Src-family kinases, Lck and Fyn, influences T-cell activation, differentiation, and tolerance. Immunol Rev 228(1):9–22. https://doi.org/10.1111/j.1600-065X.2008.00745.x
Asbach B, Ludwig C, Saksela K, Wagner R (2012) Comprehensive analysis of interactions between the Src-associated protein in mitosis of 68 kDa and the human Src-homology 3 proteome. PLoS ONE 7(6):e38540. https://doi.org/10.1371/journal.pone.0038540
Shah K, Al-Haidari A, Sun J, Kazi JU (2021) T cell receptor (TCR) signaling in health and disease. Signal Transduct Target Ther 6(1):412. https://doi.org/10.1038/s41392-021-00823-w
Volpe E, Cesari E, Mercatelli N et al (2019) The RNA binding protein Sam68 controls T helper 1 differentiation and anti-mycobacterial response through modulation of miR-29. Cell Death Differ 26(6):1169–1180. https://doi.org/10.1038/s41418-018-0201-9
Treanor B (2012) B-cell receptor: from resting state to activate. Immunology 136(1):21–27. https://doi.org/10.1111/j.1365-2567.2012.03564.x
Tokunaga R, Naseem M, Lo JH et al (2019) B cell and B cell-related pathways for novel cancer treatments. Cancer Treat Rev 73:10–19. https://doi.org/10.1016/j.ctrv.2018.12.001
Finan PM, Hall A, Kellie S (1996) Sam68 from an immortalised B-cell line associates with a subset of SH3 domains. FEBS Lett 389(2):141–144. https://doi.org/10.1016/0014-5793(96)00552-2
Sánchez-Margalet V, Najib S (2001) Sam68 is a docking protein linking GAP and PI3K in insulin receptor signaling. Mol Cell Endocrinol 183(1–2):113–121. https://doi.org/10.1016/s0303-7207(01)00587-1
Guinamard R, Fougereau M, Seckinger P (1997) The SH3 domain of Bruton’s tyrosine kinase interacts with Vav, Sam68 and EWS. Scand J Immunol 45(6):587–595. https://doi.org/10.1046/j.1365-3083.1997.d01-447.x
de Jesus AA, Chen G, Yang D et al (2023) Constitutively active Lyn kinase causes a cutaneous small vessel vasculitis and liver fibrosis syndrome. Nat Commun 14(1):1502. https://doi.org/10.1038/s41467-023-36941-y
Sanderson MP, Wex E, Kono T, Uto K, Schnapp A (2010) Syk and Lyn mediate distinct Syk phosphorylation events in FcɛRI-signal transduction: implications for regulation of IgE-mediated degranulation. Mol Immunol 48(1):171–178. https://doi.org/10.1016/j.molimm.2010.08.012
Kurosaki T, Kurosaki M (1997) Transphosphorylation of Bruton’s tyrosine kinase on tyrosine 551 is critical for B cell antigen receptor function. J Biol Chem 272(25):15595–15598. https://doi.org/10.1074/jbc.272.25.15595
Baba Y, Hashimoto S, Matsushita M et al (2001) BLNK mediates Syk-dependent Btk activation. Proc Natl Acad Sci USA 98(5):2582–2586. https://doi.org/10.1073/pnas.051626198
Desaulniers P, Fernandes M, Gilbert C, Bourgoin SG, Naccache PH (2001) Crystal-induced neutrophil activation. VII. Involvement of Syk in the responses to monosodium urate crystals. J Leukocyte Biol 70(4):659–668
Guitard E, Barlat I, Maurier F, Schweighoffer F, Tocque B (1998) Sam68 is a Ras-GAP-associated protein in mitosis. Biochem Biophys Res Commun 245(2):562–566. https://doi.org/10.1006/bbrc.1998.8374
Neumann K, Oellerich T, Urlaub H, Wienands J (2009) The B-lymphoid Grb2 interaction code. Immunol Rev 232(1):135–149. https://doi.org/10.1111/j.1600-065X.2009.00845.x
Boucher J, Kleinridders A, Kahn CR (2014) Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harbor Perspect Biol. https://doi.org/10.1101/cshperspect.a009191
Sánchez-Margalet V, Najib S (1999) p68 Sam is a substrate of the insulin receptor and associates with the SH2 domains of p85 PI3K. FEBS Lett 455(3):307–310. https://doi.org/10.1016/S0014-5793(99)00887-X
Quintana-Portillo R, Canfrán-Duque A, Issad T, Sánchez-Margalet V, González-Yanes C (2012) Sam68 interacts with IRS1. Biochem Pharmacol 83(1):78–87. https://doi.org/10.1016/j.bcp.2011.09.030
Wu W, Liu Y, Wang Y (2016) Sam68 promotes Schwann cell proliferation by enhancing the PI3K/Akt pathway and acts on regeneration after sciatic nerve crush. Biochem Biophys Res Commun 473(4):1045–1051. https://doi.org/10.1016/j.bbrc.2016.04.013
Chen L, Chen R, Wang H, Liang F (2015) Mechanisms linking inflammation to insulin resistance. Int J Endocrinol 2015:508409. https://doi.org/10.1155/2015/508409
Rehman K, Akash MS (2016) Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked? J Biomed Sci 23(1):87. https://doi.org/10.1186/s12929-016-0303-y
Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM (1994) Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 91(11):4854–4858. https://doi.org/10.1073/pnas.91.11.4854
Maroni P, Citterio L, Piccoletti R, Bendinelli P (2009) Sam68 and ERKs regulate leptin-induced expression of OB-Rb mRNA in C2C12 myotubes. Mol Cell Endocrinol 309(1–2):26–31. https://doi.org/10.1016/j.mce.2009.05.021
Villanueva EC, Myers MG Jr (2008) Leptin receptor signaling and the regulation of mammalian physiology. Int J Obesity 32(Suppl 7):S8-12. https://doi.org/10.1038/ijo.2008.232
La Cava A (2017) Leptin in inflammation and autoimmunity. Cytokine 98:51–58. https://doi.org/10.1016/j.cyto.2016.10.011
Procaccini C, Lourenco EV, Matarese G, La Cava A (2009) Leptin signaling: a key pathway in immune responses. Curr Signal Transduct Ther 4(1):22–30. https://doi.org/10.2174/157436209787048711
Li C, Friedman JM (1999) Leptin receptor activation of SH2 domain containing protein tyrosine phosphatase 2 modulates Ob receptor signal transduction. Proc Natl Acad Sci USA 96(17):9677–9682. https://doi.org/10.1073/pnas.96.17.9677
Aggarwal BB, Gupta SC, Kim JH (2012) Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey. Blood 119(3):651–665. https://doi.org/10.1182/blood-2011-04-325225
Hildt E, Oess S (1999) Identification of Grb2 as a novel binding partner of tumor necrosis factor (TNF) receptor I. J Exp Med 189(11):1707–1714. https://doi.org/10.1084/jem.189.11.1707
Lu Y, Li X, Liu S, Zhang Y, Zhang D (2018) Toll-like receptors and inflammatory bowel disease. Front Immunol 9:72. https://doi.org/10.3389/fimmu.2018.00072
Lai CY, Su YW, Lin KI, Hsu LC, Chuang TH (2017) Natural modulators of endosomal toll-like receptor-mediated psoriatic skin inflammation. J Immunol Res 2017:7807313. https://doi.org/10.1155/2017/7807313
Huang QQ, Pope RM (2009) The role of toll-like receptors in rheumatoid arthritis. Curr Rheumatol Rep 11(5):357–364. https://doi.org/10.1007/s11926-009-0051-z
Green NM, Marshak-Rothstein A (2011) Toll-like receptor driven B cell activation in the induction of systemic autoimmunity. Semin Immunol 23(2):106–112. https://doi.org/10.1016/j.smim.2011.01.016
Covacu R, Arvidsson L, Andersson A et al (2009) TLR activation induces TNF-alpha production from adult neural stem/progenitor cells. J Immunol (Baltimore, Md). 182(11):6889–6895. https://doi.org/10.4049/jimmunol.0802907
Berenbaum F, Walker C (2020) Osteoarthritis and inflammation: a serious disease with overlapping phenotypic patterns. Postgrad Med 132(4):377–384. https://doi.org/10.1080/00325481.2020.1730669
Cho Y, Jeong S, Kim H et al (2021) Disease-modifying therapeutic strategies in osteoarthritis: current status and future directions. Exp Mol Med 53(11):1689–1696. https://doi.org/10.1038/s12276-021-00710-y
Molnar V, Matišić V, Kodvanj I et al (2021) Cytokines and chemokines involved in osteoarthritis pathogenesis. Int J Mol Sci 22(17):9208
Herrero-Beaumont G, Pérez-Baos S, Sánchez-Pernaute O, Roman-Blas JA, Lamuedra A, Largo R (2019) Targeting chronic innate inflammatory pathways, the main road to prevention of osteoarthritis progression. Biochem Pharmacol 165:24–32. https://doi.org/10.1016/j.bcp.2019.02.030
Yang J, Hu S, Bian Y et al (2022) Targeting cell death: pyroptosis, ferroptosis, apoptosis and necroptosis in osteoarthritis. Front Cell Develop Biol. https://doi.org/10.3389/fcell.2021.789948
Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J (2018) Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone research 6:15. https://doi.org/10.1038/s41413-018-0016-9
Ibáñez-Costa A, Perez-Sanchez C, Patiño-Trives AM et al (2022) Splicing machinery is impaired in rheumatoid arthritis, associated with disease activity and modulated by anti-TNF therapy. Ann Rheum Dis 81(1):56–67. https://doi.org/10.1136/annrheumdis-2021-220308
Ilchovska D, Barrow DM (2021) An Overview of the NF-kB mechanism of pathophysiology in rheumatoid arthritis, investigation of the NF-kB ligand RANKL and related nutritional interventions. Autoimmun Rev 20(2):102741. https://doi.org/10.1016/j.autrev.2020.102741
Fu K, Sun X, Wier EM, Hodgson A, Hobbs RP, Wan F (2016) Sam68/KHDRBS1-dependent NF-κB activation confers radioprotection to the colon epithelium in γ-irradiated mice. Elife. https://doi.org/10.7554/eLife.21957
Xavier RJ, Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448(7152):427–434. https://doi.org/10.1038/nature06005
Silverberg MS, Satsangi J, Ahmad T et al (2005) Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 19(Suppl A):5A-36A
Artis D (2008) Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 8(6):411–420
Hooper LV, Macpherson AJ (2010) Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 10(3):159–169
Iwamoto M, Koji T, Makiyama K, Kobayashi N, Nakane PK (1996) Apoptosis of crypt epithelial cells in ulcerative colitis. J Pathol 180(2):152–159. https://doi.org/10.1002/(sici)1096-9896(199610)180:2%3c152::Aid-path649%3e3.0.Co;2-y
Hagiwara C, Tanaka M, Kudo H (2002) Increase in colorectal epithelial apoptotic cells in patients with ulcerative colitis ultimately requiring surgery. J Gastroenterol Hepatol 17(7):758–764. https://doi.org/10.1046/j.1440-1746.2002.02791.x
Edelblum KL, Yan F, Yamaoka T, Polk DB (2006) Regulation of apoptosis during homeostasis and disease in the intestinal epithelium. Inflamm Bowel Dis 12(5):413–424. https://doi.org/10.1097/01.MIB.0000217334.30689.3e
Bradford EM, Ryu SH, Singh AP et al (2017) Epithelial TNF receptor signaling promotes mucosal repair in inflammatory bowel disease. J Immunol (Baltimore, Md). 199(5):1886–1897. https://doi.org/10.4049/jimmunol.1601066
Gareb B, Otten AT, Frijlink HW, Dijkstra G, Kosterink JGW (2020) Review: local tumor necrosis factor-α inhibition in inflammatory bowel disease. Pharmaceutics. https://doi.org/10.3390/pharmaceutics12060539
Dubé PE, Punit S, Polk DB (2015) Redeeming an old foe: protective as well as pathophysiological roles for tumor necrosis factor in inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 308(3):161–170
Qian J, Zhao W, Miao X, Li L, Zhang D (2016) Sam68 modulates apoptosis of intestinal epithelial cells via mediating NF-κB activation in ulcerative colitis. Mol Immunol 75:48–59. https://doi.org/10.1016/j.molimm.2016.05.011
Mabrouk ME, Diep QN, Benkirane K, Touyz RM, Schiffrin EL (2004) SAM68: a downstream target of angiotensin II signaling in vascular smooth muscle cells in genetic hypertension. Am J Physiol Heart Circ Physiol 286(5):H1954–H1962. https://doi.org/10.1152/ajpheart.00134.2003
Lukong KE, Richard S (2003) Sam68, the KH domain-containing superSTAR. Biochem Biophys Acta 1653(2):73–86. https://doi.org/10.1016/j.bbcan.2003.09.001
Locatelli A, Lange CA (2011) Met receptors induce Sam68-dependent cell migration by activation of alternate extracellular signal-regulated kinase family members. J Biol Chem 286(24):21062–21072. https://doi.org/10.1074/jbc.M110.211409
Lukong KE, Larocque D, Tyner AL, Richard S (2005) Tyrosine phosphorylation of Sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression*. J Biol Chem 280(46):38639–38647. https://doi.org/10.1074/jbc.M505802200
Vogel G, Richard S (2012) Emerging roles for Sam68 in adipogenesis and neuronal development. RNA Biol 9(9):1129–1133. https://doi.org/10.4161/rna.21409
Benoit YD, Mitchell RR, Risueño RM et al (2017) Sam68 allows selective targeting of human cancer stem cells. Cell Chem Biol 24(7):833–44.e9. https://doi.org/10.1016/j.chembiol.2017.05.026
Benoit YD, Guezguez B, Boyd AL, Bhatia M (2014) Molecular pathways: epigenetic modulation of Wnt-glycogen synthase kinase-3 signaling to target human cancer stem cells. Clin Cancer Res 20(21):5372–5378. https://doi.org/10.1158/1078-0432.Ccr-13-2491
Masibag AN, Bergin CJ, Haebe JR et al (2021) Pharmacological targeting of Sam68 functions in colorectal cancer stem cells. iScience 24(12):103442. https://doi.org/10.1016/j.isci.2021.103442
Wu Z, Peng Y, Xiong L et al (2022) Role of Sam68 in sunitinib induced renal cell carcinoma apoptosis. Cancer Med 11(19):3674–3686. https://doi.org/10.1002/cam4.4743
Boisvert FM, Chénard CA, Richard S (2005) Protein interfaces in signaling regulated by arginine methylation. Sci STKE 2005(271):re2. https://doi.org/10.1126/stke.2712005re2
Acknowledgements
Not applicable.
Funding
P.R. is supported by NIH/NIDDK R01DK128463, NIH/NIAID grants R01AI116730 and R21AI144264, NIH/NCI grant R21 CA246194, and JDRF 3-SRA-2022-1193-S-B.
Author information
Authors and Affiliations
Contributions
PR conceived the idea and laid out the outline of this review. VG, JK, NS, and PR wrote and VG, JK and PR edited the review. VG generated the figures. VG and PR edited the figures.
Corresponding author
Ethics declarations
Conflict of interests
Authors declare no competing financial interests.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Gowd, V., Kass, J.D., Sarkar, N. et al. Role of Sam68 as an adaptor protein in inflammatory signaling. Cell. Mol. Life Sci. 81, 89 (2024). https://doi.org/10.1007/s00018-023-05108-9
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00018-023-05108-9